Global Allied pharmaceuticals (GAP) has new technology for the development of advance therapy, including immunotherapy and immune combination therapy for the treatment of various types of cancer disease that involves esophageal cancer and much more. GAP has own community of researchers, who conducts the experiments and clinical trials of new immunotherapeutic agents. For more information kindly contact us at www.gapsos.com